Retinal Detachment and Epiretinal Membrane Development in Fellow-eye Laser Prophylaxis

October 2023 Danny A. Mammo MD Cole Eye Institute, Cleveland Clinic Cleveland, OH Wingelaar MJ, Smith BT. Retinal detachment and epiretinal membrane development in fellow-eye laser prophylaxis. Journal of VitreoRetinal Diseases. 2023;7(5):371-375. This study aimed to assess the safety and effectiveness of fellow-eye laser prophylaxis (FELP) in reducing the incidence of retinal detachment (RD) in […]

Post Hoc Analysis of FILLY Trial Using AI

July 2023 Edward Korot, MD Retina Specialists of Michigan, Grand Rapids, MI Adjunct Clinical Assistant Professor, Stanford University, Palo Alto, CA   Fu DJ, Glinton S, Lipkova V, et al. Deep-learning automated quantification of longitudinal OCT scans demonstrates reduced RPE loss rate, preservation of intact macular area and predictive value of isolated photoreceptor degeneration in […]

Effect of Duration of Macular Detachment on Visual Prognosis after Surgery for Macula-Off Retinal Detachment

June 2023   Mariam Mathai, MD Location/Affiliation: The Retina Group of Washington, Washington DC Miyake M, Nakao SY, Morino K, et al. Effect of Duration of Macular Detachment on Visual Prognosis after Surgery for Macula-Off Retinal Detachment: Japan-Retinal Detachment Registry. Ophthalmol Retina. 2023;7(5):375-382. doi:10.1016/j.oret.2023.01.014   There is considerable debate regarding the allowable duration of time […]

Vitrectomy-Associated Endophthalmitis and COVID-19

April 2023 Asghar “Abbas” Haider, MD, MBA Southeastern Retina Associates, Chattanooga, TN Sakamoto, Taiji, et al. “Increased incidence of endophthalmitis after vitrectomy relative to face mask wearing during COVID-19 pandemic.” British Journal of Ophthalmology (2022).   Vitrectomy-associated endophthalmitis is a rare but severe complication that can cause significant visual impairment. Recent reports have highlighted a potential increase […]

Fellow Eye RRD Risk Stratified by Hyaloid Status on OCT at initial RRD Diagnosis

April 2023 Samir N. Patel, MD Retina Vitreous Consultants Pittsburgh PA Wallsh JO, Langevin ST, Kumar A, Huz J, Falk NS, Bhatnagar P. Fellow Eye Retinal Detachment Risk as Stratified by Hyaloid Status on Optical Coherence Tomography. Ophthalmology. 2023 Feb 9:S0161-6420(23)00105-7. doi: 10.1016/j.ophtha.2023.02.004. Epub ahead of print. PMID: 36773761.   In patients with a rhegmatogenous […]

Evaluation of Subretinal fluid Drainage Techniques During Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment – ELLIPSOID Study

January 2023 Written by:  Priya Vakharia, MD Retina Vitreous Associates of Florida Tampa Bay, FL McKay BR, Bansal A, Kryshtalskyj M, Wong DT, Berger A, Muni RH. Evaluation of Subretinal fluid Drainage Techniques During Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment-ELLIPSOID Study. Am J Ophthalmol. 2022 Sep;241:227-237. doi: 10.1016/j.ajo.2022.05.008. Epub 2022 May 18. PMID: 35597323. This […]

Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial

December 2022 Written by:  Jordan Deaner, MD Mid Atlantic Retina / Wills Eye Hospital Philadelphia, PA Rush RB, Velazquez JC, Rosales CR, Rush SW. Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial. Am J Ophthalmol. 2022;242:173-180. doi:10.1016/j.ajo.2022.06.015 Disclosures: EyePoint – Consultant, Alimera – Consultant Vitreous hemorrhage (VH) […]

Efficacy and Safety of Biosimilar FYB201 Compared With Ranibizumab in Neovascular Age-Related Macular Degeneration

December 2022 Written by:  Jordan Deaner, MD Mid Atlantic Retina / Wills Eye Hospital Philadelphia, PA Holz FG, Oleksy P, Ricci F, et al. Efficacy and safety of biosimilar FYB201 compared with ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2022;129(1):54-63.   Recently the United States Food and Drug Administration (USFDA) approved the first interchangeable biosimilar for use […]